Kilombero and Ulanga antiretroviral cohort study...

In the News

Muhas don is new IHI board member

Prof. Kaaya. Ifakara Health Institute (IHI) Board of Governors (BOG) has appointed Prof. Sylvia Kaaya member of the IHI Board of Trustees (BOT) effective Wednesday January 10, 2018. The appointment …

Marcel steps down from IHI boards

Prof. Marcel Tanner has stepped down as Ifakara Health Institute (IHI) member of the Board of Trustees (BOT) and Board of Governors (BOG) effective Wednesday January 10, 2018. The Former …

Recent Projects

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Demonstrating complete disruption of residual malaria transmission by eliminating Anopheles funestus mosquitoes from rural Tanzanian villages

In rural south-eastern Tanzania, where malaria prevalence has reduced by >60% since 2000, low-to-moderate transmission still persists despite very high coverage with long-lasting insecticidal bednets. Like in most residual transmission …

Kilombero and Ulanga Antiretroviral Cohort Study (KIULARCO)

In 2005 a cohort study of HIV-positive patients at the St Francis Referral Hospital, Ifakara was started. Patients consenting to be regularly seen in the Chronic Diseases Clinic Ifakara (CDCI), to have their data analyzed and blood stored in a biobank for further analysis are prospectively enrolled. The cohort offers the opportunity for many nested research projects addressing questions on prevalence of associated diseases, clinical management and outcomes, aiming at addressing specific needs of this rural population and at improvement of services. A special focus is co-infection with tuberculosis, cryptococcal meningitis, and other co-morbidities. Pediatric HIV infection – considered a neglected disease – and HIV in pregnant women is an important research line. So far, almost 9000 patients have been enrolled, of these 3500 are currently under active follow-up. 18 papers have been published; many more are in preparation or currently running. KIULARCO also offers an ideal platform for affiliated treatment studies – within international collaborations or as single center study.

Lead Scientists

Maja Weisser

Herry Mapesi

George Sekilango


Swiss Tropical and Public Health Insitute


Ifakara Health Institute
Swiss Tropical and Public Health Institute

Projects Location

© Ifakara Health Institute (IHI), 2016